Jane Street
KRTX

Jane Street’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jane Street’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,100
Closed -$15.9M – 10355
2023
Q4 		$15.9M Buy
50,100
+20,900
+72% +$4.06M ﹤0.01% 1482
2023
Q3 		$4.94M Sell
29,200
-16,000
-35% -$3.01M ﹤0.01% 2631
2023
Q2 		$9.8M Buy
45,200
+25,400
+128% +$5.44M ﹤0.01% 1922
2023
Q1 		$3.6M Sell
19,800
-5,600
-22% -$1.07M ﹤0.01% 2892
2022
Q4 		$4.99M Sell
25,400
-14,000
-36% -$3M ﹤0.01% 2486
2022
Q3 		$8.86M Sell
39,400
-27,400
-41% -$5.55M ﹤0.01% 1816
2022
Q2 		$8.45M Buy
66,800
+34,100
+104% +$3.92M ﹤0.01% 1943
2022
Q1 		$4.15M Buy
32,700
+17,700
+118% +$1.99M ﹤0.01% 3354
2021
Q4 		$1.97M Buy
+15,000
New +$1.94M ﹤0.01% 4532
2021
Q2 		– Sell
-5,000
Closed -$601K – 10599
2021
Q1 		$601K Sell
5,000
-4,100
-45% -$464K ﹤0.01% 6469
2020
Q4 		$924K Buy
9,100
+4,000
+78% +$371K ﹤0.01% 4783
2020
Q3 		$394K Buy
5,100
+2,100
+70% +$179K ﹤0.01% 5518
2020
Q2 		$334K Buy
+3,000
New +$261K ﹤0.01% 5676

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jane Street's KRTX Position: Q1 2024 in Review

Jane Street sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,456 shares — an estimated $1.09M sold.

Jane Street first reported a position in KRTX in Q4 2019 and held it in 12 quarters. The position peaked at $13M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Jane Street reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 3,456 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.09M.
  • Jane Street first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Jane Street's Karuna Therapeutics, Inc. Common Stock position peaked at $13M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.